We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Check the tariff classification for a defined daily dose of active substances.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Two pharmacists who sold ‘industrial’ quantities of Class C controlled drugs were yesterday sentenced to two years’ imprisonment each, suspended for 24 months, at Southwark Crown Court following an investigation by the Criminal Enforcement Unit of the Medicines and Healthcare...
This document (RCE-5) provides guidance on the application of these dose coefficients in relation to different exposure situations.
Typical effective doses, equivalent periods of natural background radiation and lifetime fatal cancer risks from diagnostic medical exposures.
Recommended method for estimating radiation doses from inhalation of resuspended materials in emergency situations.
Information for healthcare professionals and the public about the Pfizer/BioNTech's bivalent vaccines
Odds ratios for symptoms reported at least 12 weeks after coronavirus (COVID-19) infection, comparing COVID-19 Infection Survey participants who had received two doses of a COVID-19 vaccine before infection to those who were unvaccinated
Comparison of doses from sources of exposure.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).